COMPARATIVE STUDY BETWEEN BELOTECAN/CISPLATIN AND ETOPOSIDE/CISPLATIN (COMBAT) IN PATIENTS WITH PREVIOUSLY UNTREATED, EXTENSIVE STAGE SMALL CELL LUNG CANCER

被引：0
|
作者：
Oh, In-Jae [1 ]
Kim, Kyu-Sik [1 ]
Kim, Young-Chul [1 ]
Na, Kook-Joo [1 ]
Ahn, Sung-Ja [1 ]
Song, Sang-Yun [1 ]
Choi, Yoo-Duk [1 ]
Yoon, Seong-Hoon [1 ]
Lee, Boram [1 ]
Yu, Jinyeong [1 ]
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Lung Canc Clin, Kwangju, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
belotecan; small cell lung cancer; topoisomerase I inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.10-031
引用
收藏
页码：S1171 / S1171
页数：1
相关论文
共 50 条
  • [41] Comparison of etoposide/cisplatin and irinotecan/cisplatin for extensive-stage small cell lung cancer in Koreans: A real-world retrospective observational study
    Lee, E.
    Yoo, S. S.
    Choi, S. H.
    Seo, H.
    Lee, S. Y.
    Cha, S. I.
    Kim, C. H.
    Park, J. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S134 - S135
  • [42] Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive stage small cell lung cancer (ED-SCLC) (final report).
    Ohe, Y
    Negoro, S
    Matsui, K
    Nakagawa, K
    Sugiura, T
    Takada, Y
    Nishiwaki, Y
    Saijo, N
    Fukuoka, M
    Ariyoshi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [43] Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
    Sorensen, Morten
    Lassen, Ulrik
    Jensen, Peter Buhl
    Osterlind, Kell
    Jeppesen, Nina
    Jensen, Britta Bjerregaard
    Mellemgaard, Anders
    Rytter, Carsten
    Langer, Seppo Wang
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 902 - 906
  • [44] A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer
    Sorensen, M
    Jensen, PB
    Herrstedt, J
    Hirsch, FR
    Hansen, HH
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 829 - 835
  • [45] Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer
    Kudoh, S
    Fujiwara, Y
    Takada, Y
    Yamamoto, H
    Kinoshita, A
    Ariyoshi, Y
    Furuse, K
    Fukuoka, M
    Takada, M
    Ikegami, H
    Nishikawa, H
    Nakajima, S
    Hoso, T
    Higashino, K
    Takahara, J
    Kamei, M
    Yamakido, M
    Ryu, S
    Hara, N
    Fukuda, M
    Kinuwaki, E
    Tanaka, F
    Senba, H
    Araki, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) : 1068 - 1074
  • [46] h Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial
    Shi, Yuankai
    Hu, Yi
    Hu, Xingsheng
    Li, Xue
    Lin, Lin
    Han, Xiaohong
    THORACIC CANCER, 2015, 6 (06) : 785 - 791
  • [47] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Owonikoko, Taofeek K.
    Aisner, Joseph
    Wang, Xin Victoria
    Dahlberg, Suzanne E.
    Rubin, Eric H.
    Ramalingam, Suresh S.
    Gounder, Murugesan
    Rausch, Paul Gregory
    Axelrod, Rita S.
    Schiller, Joan H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 171 - 180
  • [48] Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501
    Horn, Leora
    Dahlberg, Suzanne E.
    Sandler, Alan B.
    Dowlati, Afshin
    Moore, Dennis F.
    Murren, John R.
    Schiller, Joan H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : 6006 - 6011
  • [49] E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
    Taofeek K. Owonikoko
    Joseph Aisner
    Xin Victoria Wang
    Suzanne E. Dahlberg
    Eric H. Rubin
    Suresh S. Ramalingam
    Murugesan Gounder
    Paul Gregory Rausch
    Rita S. Axelrod
    Joan H. Schiller
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 171 - 180
  • [50] Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer
    Hong, Junshik
    Jung, Minkyu
    Kim, Yu Jin
    Sym, Sun Jin
    Kyung, Sun Young
    Park, Jinny
    Lee, Sang Pyo
    Park, Jeong Woong
    Cho, Eun Kyung
    Jeong, Sung Hwan
    Shin, Dong Bok
    Lee, Jae Hoon
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 215 - 220
12345